ResMed
730 hedge funds and large institutions have $20.8B invested in ResMed in 2023 Q2 according to their latest regulatory filings, with 95 funds opening new positions, 256 increasing their positions, 252 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.16% more ownership
Funds ownership: 64.7% → 64.87% (+0.16%)
1% less capital invested
Capital invested by funds: $20.9B → $20.8B (-$125M)
10% less funds holding in top 10
Funds holding in top 10: 10 → 9 (-1)
Holders
730
Holding in Top 10
9
Calls
$189M
Puts
$24.9M
Top Buyers
| 1 | +$141M | |
| 2 | +$106M | |
| 3 | +$91.6M | |
| 4 |
Jane Street
New York
|
+$69M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$64.3M |
Top Sellers
| 1 | -$422M | |
| 2 | -$201M | |
| 3 | -$90.2M | |
| 4 |
Amundi
Paris,
France
|
-$71.8M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$56.3M |